Sort
48,018 grants matching “immunotherapy”
The regulation and function of CD1d-restricted T cells
$386,250Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2017 · AI
Blockade of T-cell Co-Inhibitory Pathways & Immunotherapy to Prevent Ocular Herpe
$386,250Lbachir Benmohamed · University Of California-Irvine · R01 · FY2014 · EY
Characterization of neutralizing antitoxins and epitopes in Clostridium difficile patients
$386,250Hanping Feng · University Of Maryland Baltimore · R01 · FY2020 · AI
Informatics tools for identification, prioritization and clinical application of neoantigens
$386,237Malachi Griffith · Washington University · U01 · FY2022 · CA
Specific activation of latent HIV-1 by inhibiting E3 ubiquitin ligase activity
$386,234Celine Gelinas · Rbhs-Robert Wood Johnson Medical School · R33 · FY2017 · AI
Specific activation of latent HIV-1 by inhibiting E3 ubiquitin ligase activity
$386,234Celine Gelinas · Rbhs-Robert Wood Johnson Medical School · R33 · FY2018 · AI
Pathogensis of Bacterial corneal infection
$386,233Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2011 · EY
Radioimmunotherapy Combinations for B-cell Malignancy
$386,220Damian J. Green · University Of Miami School Of Medicine · R01 · FY2025 · CA
Targeting Viral Envelope Glycoproteins with Synthetic Antibodies
$386,199Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2013 · AI
Molecular Tailoring of Bispecific AntibodyâBottlebrushConjugates
$386,194Jeremiah Allen Johnson · Massachusetts Institute Of Technology · R21 · FY2025 · AI
Controlled Release of Macromolecules
$386,153Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2011 · EB
Il-27-mediated immunoregulation in HSV-1 induced stromal keratitis
$386,146Amol Suryawanshi · North Carolina State University Raleigh · R01 · FY2025 · EY
Mechanisms of the induction of oral tolerance
$386,146Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2007 · AI
Strategies to Enhance Adoptive Transfer T Cell Clones
$386,144Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma
$386,138Amyn Habib · Ut Southwestern Medical Center · R01 · FY2020 · CA
Novel Mechanisms Regulating Posttransplant Humoral Alloimmunity
$386,134Ginny L Bumgardner · Ohio State University · R01 · FY2011 · AI
The function of PLZF in innate T cells
$386,100Derek B. Sant'angelo · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · AI
Cytokine Gene Expression During In Vivo Immune Response
$386,100William Clark Gause · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · AI
NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT
$386,095Nsabp Foundation, Inc. · U10 · FY2003 · CA
Regulation of Tumor Oxygenation by BACH1 in Breast Cancer
$386,091Marsha R Rosner · University Of Chicago · R01 · FY2024 · CA
Seattle-Lausanne Clinical Trials Unit
$386,073Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$386,069Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · CA
Immune activation by necroptotic cell death
$386,054Andrew Atwell Oberst · University Of Washington · R01 · FY2019 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$386,039Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$386,033Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2021 · NS